ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
92,600
-900 (-0.96%)
Aug 29, 2025, 3:30 PM KST

ST Pharm Statistics

Total Valuation

ST Pharm has a market cap or net worth of KRW 1.88 trillion. The enterprise value is 1.91 trillion.

Market Cap1.88T
Enterprise Value 1.91T

Important Dates

The next estimated earnings date is Friday, October 31, 2025.

Earnings Date Oct 31, 2025
Ex-Dividend Date Dec 27, 2024

Share Statistics

ST Pharm has 20.15 million shares outstanding. The number of shares has increased by 6.71% in one year.

Current Share Class 20.15M
Shares Outstanding 20.15M
Shares Change (YoY) +6.71%
Shares Change (QoQ) +0.15%
Owned by Insiders (%) 7.60%
Owned by Institutions (%) 10.18%
Float 12.44M

Valuation Ratios

The trailing PE ratio is 55.44 and the forward PE ratio is 37.88.

PE Ratio 55.44
Forward PE 37.88
PS Ratio 6.32
PB Ratio 3.77
P/TBV Ratio 3.89
P/FCF Ratio n/a
P/OCF Ratio 26.68
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.61, with an EV/FCF ratio of -238.16.

EV / Earnings 56.37
EV / Sales 6.42
EV / EBITDA 27.61
EV / EBIT 44.94
EV / FCF -238.16

Financial Position

The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.24.

Current Ratio 2.18
Quick Ratio 0.99
Debt / Equity 0.24
Debt / EBITDA 1.70
Debt / FCF -14.73
Interest Coverage 5.53

Financial Efficiency

Return on equity (ROE) is 6.94% and return on invested capital (ROIC) is 4.44%.

Return on Equity (ROE) 6.94%
Return on Assets (ROA) 3.83%
Return on Invested Capital (ROIC) 4.44%
Return on Capital Employed (ROCE) 7.32%
Revenue Per Employee 455.13M
Profits Per Employee 51.81M
Employee Count 655
Asset Turnover 0.43
Inventory Turnover 1.18

Taxes

In the past 12 months, ST Pharm has paid 10.61 billion in taxes.

Income Tax 10.61B
Effective Tax Rate 24.78%

Stock Price Statistics

The stock price has decreased by -19.32% in the last 52 weeks. The beta is 0.45, so ST Pharm's price volatility has been lower than the market average.

Beta (5Y) 0.45
52-Week Price Change -19.32%
50-Day Moving Average 87,706.00
200-Day Moving Average 83,288.50
Relative Strength Index (RSI) 56.58
Average Volume (20 Days) 112,038

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ST Pharm had revenue of KRW 298.11 billion and earned 33.94 billion in profits. Earnings per share was 1,686.52.

Revenue298.11B
Gross Profit 110.27B
Operating Income 42.82B
Pretax Income 42.82B
Net Income 33.94B
EBITDA 69.53B
EBIT 42.82B
Earnings Per Share (EPS) 1,686.52
Full Income Statement

Balance Sheet

The company has 89.13 billion in cash and 118.30 billion in debt, giving a net cash position of -29.17 billion or -1,447.29 per share.

Cash & Cash Equivalents 89.13B
Total Debt 118.30B
Net Cash -29.17B
Net Cash Per Share -1,447.29
Equity (Book Value) 500.45B
Book Value Per Share 24,860.55
Working Capital 174.89B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 70.63 billion and capital expenditures -78.66 billion, giving a free cash flow of -8.03 billion.

Operating Cash Flow 70.63B
Capital Expenditures -78.66B
Free Cash Flow -8.03B
FCF Per Share -398.55
Full Cash Flow Statement

Margins

Gross margin is 36.99%, with operating and profit margins of 14.36% and 11.38%.

Gross Margin 36.99%
Operating Margin 14.36%
Pretax Margin 14.36%
Profit Margin 11.38%
EBITDA Margin 23.32%
EBIT Margin 14.36%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 0.53%.

Dividend Per Share 500.00
Dividend Yield 0.53%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 29.69%
Buyback Yield -6.71%
Shareholder Yield -6.18%
Earnings Yield 1.80%
FCF Yield -0.43%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ST Pharm has an Altman Z-Score of 5.72 and a Piotroski F-Score of 6.

Altman Z-Score 5.72
Piotroski F-Score 6